Business Combination — Goodwill Recognition
Recording goodwill arising from the acquisition of a pharmaceutical company.
| Account Name | Type | Debit ($) | Credit ($) |
|---|---|---|---|
| Goodwill (Acquisition) | Asset (+) | 2,500,000,000.00 | - |
| Net Identifiable Assets Acquired (Fair Value) | Asset (+) | - | - |
| Consideration Transferred (Cash + Contingent) | Liability/Asset (-) | - | 2,500,000,000.00 |
💡 Accountant's Note
In pharma business combinations, goodwill represents the excess of the purchase price over the fair value of identifiable net assets (drug patents, pipeline IPR&D, manufacturing assets, workforce). Pharma acquisitions carry substantial goodwill due to the value of the acquired organisation's capabilities, relationships, and expected synergies.
Practitioner & Systems Framework
💻 ERP Architecture
Goodwill from pharma acquisitions is calculated as the purchase price minus the fair value of net identifiable assets. The IFRS 3 purchase price allocation (PPA) identifies and values: approved drug patents, pipeline IPR&D, manufacturing facilities, trade names, customer relationships, and workforce. The PPA is a complex valuation exercise requiring specialist pharma IP valuers — it must be completed within 12 months of acquisition. Goodwill is not amortised under IFRS but is tested for impairment annually (or more frequently if impairment indicators arise). For large pharma acquisitions, goodwill and other intangibles may represent 70-80% of the total purchase price.
⚠️ Audit Flags
Auditors engage their own valuation specialists to independently assess the PPA, particularly the fair values allocated to drug patents and IPR&D. The split between identifiable intangibles and goodwill is subjective — inflating identifiable intangibles reduces goodwill but increases future amortisation charge (affecting GAAP earnings). Test that the 12-month PPA measurement period is adhered to. Confirm that contingent consideration (CVRs — Contingent Value Rights based on sales milestones) is measured at fair value at acquisition and remeasured each period. Assess the goodwill impairment test CGU (Cash-Generating Unit) allocation and the key assumptions in the impairment model.
📄 Required Documentation
Acquisition agreement (including contingent consideration terms), independent PPA report (fair value of identifiable assets), goodwill calculation, IFRS 3 measurement period adjustment register, annual goodwill impairment test (with DCF model and key assumptions), CVR liability fair value measurement, and financial statement disclosures on business combinations.
Professional Excel Template
Get the automated version of this entry. Includes built-in IFRS checks, VAT calculators, and SAP-ready upload formats.
Expert Analysis by Qusai Ahmad
General Accountant Supervisor & IFRS Specialist
Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.